BOK Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,917
Closed -$278K 1185
2022
Q4
$278K Hold
9,917
0.01% 776
2022
Q3
$356K Sell
9,917
-66
-0.7% -$2.33K 0.01% 724
2022
Q2
$306K Sell
9,983
-450
-4% -$13.1K 0.01% 772
2022
Q1
$337K Sell
10,433
-188
-2% -$4.92K 0.01% 814
2021
Q4
$294K Sell
10,621
-55
-0.5% -$1.58K ﹤0.01% 833
2021
Q3
$331K Buy
+10,676
New +$256K 0.01% 792
2021
Q1
$230K Buy
11,379
+555
+5% +$10.6K ﹤0.01% 845
2020
Q4
$173K Buy
+10,824
New +$143K ﹤0.01% 881

Other funds holding EVH

BOK Financial's EVH Position: Q1 2023 in Review

BOK Financial sold out of Evolent Health (EVH) in Q1 2023, closing a stake of 9,917 shares — an estimated $278K sold.

BOK Financial first reported a position in EVH in Q4 2020 and held it in 8 quarters. The position peaked at $356K in Q3 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q1 2023.

  • BOK Financial reported no remaining Evolent Health position as of Q1 2023 after selling out during the quarter.
  • BOK Financial sold 9,917 Evolent Health shares in Q1 2023, an estimated $278K.
  • BOK Financial first reported a position in Evolent Health in Q4 2020 and held it in 8 quarters.
  • BOK Financial's Evolent Health position peaked at $356K in Q3 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q1 2023.

Based on BOK Financial's 13F filing for Q1 2023, filed 11 May 2023.